PROYECTOS EUROPEOS
Projet DIRNANO DIRNANO
Directing the immune response through designed nanomaterials
date_range
Durée de 01 octobre 2020 à 30 septembre 2024
(48 mois)
euro
259 904,00 EUR
Sphère Européen.
Chercheurs
Francisco
Corzana López
Responsable
Publications liées au projet
Montrer par typologie2023
-
Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
VI RSEQ Chemical Biology Group Meeting - ChemBio VI
-
Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays
4th Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models
3rd Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development
5th Regular Meeting of the DIRNANO consortium
2022
-
Directing the immune response through designed nanomaterial. Winter School Presentation
Winter School of the DIRNANO consortium
-
Directing the immune response through designed nanomaterials. Progress Report
1st Regular Meeting of the DIRNANO consortium
Données de recherche liées
- PRESENTATION 2nd Regular Meeting of the DIRNANO consortium; ESR14